Characterization of gelatinases in bronchoalveolar lavage fluid and gelatinases produced by alveolar macrophages isolated from healthy calves

American Journal of Veterinary Research

Volumn 65, Issue 2, 2004, Pages 163-172

  Lakritz, Jeffrey ^a,c   Marsh, Antoinette E ^a   Cockrell, Mary ^a   Smith, Michael F ^b   Tyler, Jeff W ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MESSENGER RNA; METAL CHELATE; SERINE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ISOENZYME; NITRIC OXIDE SYNTHASE; PRIMER DNA; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; IMMUNOBLOTTING; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY; ANIMAL; CATTLE; CHEMISTRY; COMPARATIVE STUDY; DNA SEQUENCE; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ANIMALIA;

ANIMALS; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CATTLE; CYCLOOXYGENASE 2; DNA PRIMERS; GELATINASES; IMMUNOBLOTTING; ISOENZYMES; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASES; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 1542360615     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.163     Document Type: Article

References (58)

1. Drummond RO, Lambert G, Smalley HE, et al. Estimated losses of livestock to pests. In: Pimentel D, ed. CRC Handbook of pest management in agriculture. Vol 1. Boca Raton, Fla: CRC Press Inc, 1981;111-127.
2. Frank GH. Pasteurellosis of cattle. In: Adlam C, Rutter JM, eds. Pasteurella and pasteurellosis. New York: Academic Press Inc, 1989;197-222.
3. Yates WD. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 1982;46:225-263.
4. Wikse SE. Feedlot cattle pneumonia. Vet Clin North Am Food Anim Pract 1985;1:289-310.
5. Rehmtulla AJ, Thomson RG. A review of the lesions of shipping fever of cattle. Can Vet J 1981;22:1-8.
6. Mosier DA. Bacterial pneumonia. Vet Clin North Am Food Anim Pract 1997;13:483-493.
7. Weekley LB, Veit HP, Eyre P. Bovine pneumonic pasteurellosis. Part I. Pathophysiology. Compend Contin Educ Pract Vet 1998;20:S33-S46.
8. Young C. Antimicrobial metaphylaxis for undifferentiated bovine respiratory disease. Compend Contin Educ Pract Vet 1995;17:133-145.
9. Liggitt HD. Defense mechanisms in the bovine lung. Vet Clin North Am Food Anim Pract 1985;1:347-366.
10. Tyler WS. Comparative subgross anatomy of the lungs. Pleuras, interlobular septa, and distal airways. Am Rev Respir Dis 1983;128:S32-S36.
11. Robinson NE. Some functional consequences of species differences in lung anatomy. Adv Vet Sci Comp Med 1982;26:1-33.
12. Ackermann MR, Brogden KA. Response of the ruminant respiratory tract to Mannheimia (Pasteurella) haemolytica. Microbes Infect 2000;2:1079-1088.
13. Slocumbe RF, Malark J, Ingersoll R, et al. Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am J Vet Res 1985;46:2253-2258.
14. Weiss DJ, Bauer MC, Whiteley LO, et al. Changes in blood and bronchoalveolar lavage fluid components in calves with experimentally induced pneumonic pasteurellosis. Am J Vet Res 1991;52:337-344.
15. Werb Z. Proteinases and matrix degradation. In: Kelley WN, Harris ED, Ruddy S, et al, eds. Textbook of rheumatology. 3rd ed. Philadelphia: WB Saunders Co, 1989;300-321.
16. Esparza J, Vilardell C, Calvo J, et al. Fibronectin upregulates gelatinase B (MMP 9) and induces coordinated expression of gelatinase A (MMP 2) and its activator MT1-MMP (MMP 14) by human T-lymphocyte cell lines: a process repressed through RAS/MAP kinase signaling pathways. Blood 1999;94:2754-2766.
17. Delclaux C, Delacourt C, D'Ortho MP, et al. Role of gelatinase B and elastase in human neutrophil migration across the basement membrane. Am J Respir Cell Mol Biol 1996;14:288-295.
18. Radi ZA, Kehrli ME, Ackermann MR. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J Vet Intern Med 2001;15:516-529.
19. Leppert D, Waubant E, Galardy R, et al. T-cell gelatinases mediated basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389.
20. Gibbs DF, Warner RL, Weiss SJ, et al. Characterization of matrix metalloproteinases produced by alveolar macrophages. Am J Respir Cell Mol Biol 1999;20:1136-1144.
21. Corbel M, Theret N, Caulet-Maugendre S, et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 2001;50:129-135.
22. Lemjabbar H, Gosset P, Lechapt-Zalcman E, et al. Overexpression of alveolar macrophage gelatinase B (MMP 9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 1999;20: 903-913.
23. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997;156:240-247.
24. Kelly EA, Busse WW, Jarjour NN. Increased MMP-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162: 1157-1161.
25. Ratjen F, Hartog CM, Paul K, et al. Matrix metalloproteinases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax 2002;57:930-934.
26. Raulo SM, Sorsa TA, Tervahartiala T, et al. MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar lavage fluid (BALF) of COPD horses. Equine Vet J 2001;33:1128-1136.
27. Rajamaki MM, Jarvinen AK, Sorsa T, et al. Clinical findings, bronchoalveolar lavage fluid cytology and MMP-2 and -9 in canine pulmonary eosinophilia. Vet J 2002;163:168-181.
28. Raulo SM, Sorsa TA, Maisi PS. Concentrations of elastolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease. Am J Vet Res 2000;61:1067-1073.
29. Corry DB, Rishi K, Kanellis J, et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP 2-deficiency. Nature Immunol 2002;3:347-353.
30. Thieblemont N, Wright SD. Transport of bacterial lipopolysaccharide to the Golgi apparatus. J Exp Med 1999;190:523-534.
31. Vasselon T, Hailman E, Thieringer R, et al. Internalization of monomeric LPS occurs after transfer out of cell surface CD14. Exp Med 1999;190:509-521.
32. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing SDS and copolymerized substrates. Anal Biochem 1980;102:196-202.
33. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanididium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
34. 2 production via a mechanism involving phospholipases. Vet Ther 2002;3:7-21.
35. Taylor K, Lutje V, Mertens B. Nitric oxide is depressed in Bos Indicus cattle infected with Trypanosoma congolense and Trypanosoma vivax and does not mediate T-cell suppression. Infect Immun 1996;64:4115-4122.
36. Tuo W, MacMillan H, Gunter N, et al. Upregulation of interleukin-4 and IFN-gamma expression by IFN-tau, a member of the type I IFN family. J Interferon Cytokine Res 1999;19:179-187.
37. Asselin E, Drolet P, Fortier MA. Cellular mechanisms involved during oxytocin-incluced prostaglandin F2α production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology 1997;138:4798-4805.
38. Adler H, Frech B, Thony H, et al. Inducible nitric oxide synthase in cattle: differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J Immunol 1995;154:4710-4718.
39. Balcerzak D, Querengesser L, Dixon WT, et al. Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle. J Anim Sci 2001;79:94-107.
40. Li X, Zhao X, Ma S. Secretion of 92 kDa gelatinase (MMP-9) by bovine neutrophils. Vet Immunol Immunopathol 1999;67:247-258.
41. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-19.
42. Raulo SM, Sorsa T, Tervahartiala T, et al. Increase in milk metalloproteinase activity and vascular permeability in bovine endotoxin-induced and naturally occurring E. coli mastitis. Vet Immunol Immunopathol 2002;85:137-145.
43. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 1999;100:400-406.
44. Knauper V, Reinke H, Tschesche H. Inactivation of human plasma α1-proteinase inhibitor by human PMN leukocyte collagenase. FEBS Lett 1990;263:355-357.
45. Vissers MC, George PM, Bathurst IC, et al. Cleavage and inactivation of α1-antitrypsin by metalloproteinases released from neutrophils. J Clin Invest 1988;82:706-711.
46. Knauper V, Triebel S, Reinke H, et al. Inactivation of human plasma Cl-inhibitor by human PMN leukocyte MMP. FEBS Lett 1991;290:99-102.
47. Van den Steen PE, Proost P, Wuyts A, et al. Neutrophil gelatinase B potentiates IL-8 tenfold by amino-terminal processing, whereas it degrades CTAP-III, PF-4, GRO-α and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681.
48. Arican M, Coughlan AR, Clegg PD, et al. Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids. J Vet Med A Physiol Pathol Clin Med 2000;47:449-456.
49. Bakke LJ, Dow MP, Cassar CA, et al. Effect of preovulatory gonadotropin surge on MMP-14, MMP-2 and TIMP-2 expression within bovine pre-ovulatory follicular and luteal tissue. Biol Reprod 2002;66:1627-1634.
50. Ricke WA, Smith GW, McIntush EW, et al. Analysis of luteal tissue inhibitor of metalloproteinase-1, -2, and -3 during PGF2α-induced luteolysis. Biol Reprod 2002;66:1387-1394.
51. McIntush EW, Smith MF. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 1998;3:23-30.
52. Opdenakker G, Van den Steen PE, Dubois B, et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001;69:851-859.
53. Atkinson JJ, Senior RM. Matrix metalloproteinase 9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
54. Tournier JM, Polette M, Hinnrasky J, et al. Expression of gelatinase A, a mediator of extracellular matrix remodeling, by tracheal gland serous cells in culture and in vivo. J Biol Chem 1994;269:25454-25464.
55. Yao PM, Buhler JM, D'Ortho MP, et al. Expression of MMP gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 1996;271:15580-15589.
56. Yu AE, Murphy AN, Stetler-Stevenson WG. 72-kDa gelatinase (Gelatinase A): structure, activation, regulation, and substrate specificity. In: Parks WC, Mecham RP, eds. Matrix metalloproteinases. San Diego: Academic Press Inc, 1998;85-114.
57. 3. Cell 1996;85:683-693.
58. Hotary KB, Yana I, Sabeh F, et al. Matrix metalloproteinases (MMP's) regulate fibrin-invasive activity via MT1-MMP-dependent and independent processes. J Exp Med 2002;195:295-308.